Update on optimal management for pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty

2021 ◽  
Author(s):  
Mike Nguyen ◽  
Eva Segelov ◽  
David Goldstein ◽  
Nick Pavlakis ◽  
Jeremy Shapiro ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Optimal Management ◽  
International Faculty

Optimal Management of the Splenic Vein at the Time of Venous Resection for Pancreatic Cancer: Importance of the Inferior Mesenteric Vein

2013 ◽  
Vol 18 (5) ◽  
pp. 917-921 ◽  
Author(s):  
Charles H. C. Pilgrim ◽  
Susan Tsai ◽  
Parag Tolat ◽  
Parag Patel ◽  
William Rilling ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Splenic Vein ◽  
Inferior Mesenteric Vein ◽  
Optimal Management ◽  
Venous Resection ◽  
Mesenteric Vein

What is optimal management of borderline resectable pancreatic cancer? - A multi-institutional analysis

Pancreatology ◽  
2017 ◽  
Vol 17 (3) ◽  
pp. S90
Author(s):  
Yuichi Nagakawa ◽  
Yuichi Hosokawa ◽  
Yatsuka Sahara ◽  
Chie Takishita ◽  
Takukazu Nagakawa ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Institutional Analysis ◽  
Optimal Management ◽  
Resectable Pancreatic Cancer ◽  
Borderline Resectable ◽  
Borderline Resectable Pancreatic Cancer

scholarly journals Computed tomography-guided cryoablation of local recurrence after primary resection of pancreatic adenocarcinoma

2015 ◽  
Vol 5 (2) ◽  
Author(s):  
Claudio Pusceddu ◽  
Luca Melis ◽  
Barbara Sotgia ◽  
Alessandro Fancellu ◽  
Giovanni Battista Meloni
Keyword(s):  
Computed Tomography ◽  
Pancreatic Cancer ◽  
Local Recurrence ◽  
Pancreatic Surgery ◽  
Cancer Recurrence ◽  
Multimodality Treatment ◽  
Primary Resection ◽  
Optimal Management ◽  
Percutaneous Cryoablation

The optimal management of local recurrences after primary resection of pancreatic cancer still remains to be clarified. A 58-yearold woman developed an isolated recurrence of pancreatic cancer six year after distal pancreatectomy. Re-resection was attempted but the lesion was deemed unresectable at surgery. Then chemotherapy was administrated without obtaining a reduction of the tumor size nor an improvement of the patient’s symptoms. Thus the patient underwent percutaneous cryoablation under computed tomography (CT)-guidance obtaining tumor necrosis and a significant improvement in the quality of life. A CT scan one month later showed a stable lesion with no contrast enhancement. While the use of percutaneous cryoblation has widened its applications in patients with unresectable pancreatic cancer, it has never been described for the treatment of local pancreatic cancer recurrence after primary resection. Percutaneous cryoablation deserves further studies in the multimodality treatment of local recurrence after primary pancreatic surgery.

Expression of the melanoma antigen-encoding gene in pancreatic cancer

2001 ◽  
Vol 120 (5) ◽  
pp. A162-A162
Author(s):  
A KUTUP ◽  
S HOSCH ◽  
S PAPE ◽  
P SCHEUNEMANN ◽  
W KNOEFEL ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Melanoma Antigen ◽  
Encoding Gene
Sign in / Sign up

Export Citation Format

Share Document